SCHEMBL806181

SCHEMBL806181

NC(=O)Cc1nnn[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9074013 0.80
SCHEMBL595749 0.80
SCHEMBL3073811 0.80
SCHEMBL550435 0.79 CAPN1 (0.35)
SCHEMBL1640066 0.78
SCHEMBL1259219 0.78
SCHEMBL10369757 0.77 CA12 (0.33)
SCHEMBL10856590 0.77 F2 (0.32)
Ethylene SCHEMBL6555998 0.77 CSNK2A2 (0.31)
SCHEMBL10678782 0.76 TBXAS1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110144033-A1 Proteasome Inhibitors and Methods of Using the Same CEPHALON, INC. (US) 2011-06-16 US claimed
US-7915236-B2 Proteasome inhibitors and methods of using the same CEPHALON, INC. (US) 2011-03-29 US claimed
CN-101952289-A Fused pentacyclic derivatives for use in the treatment of flavivirus infections GENELABS TECH INC 2011-01-19 CN claimed
EP-2170876-A2 PHARMACEUTICAL COMPOSITION FOR PREVENTINTION AND TREATMENT OF RESTENOSIS COMPRISING ISOXAZOLE DERIVATIVES SK Holdings Co., Ltd. (KR) 2010-04-07 EP claimed
EP-1660507-B9 PROTEASOME INHIBITORS AND METHODS OF USING THE SAME CEPHALON INC (US) 2010-03-24 EP claimed
US-20090291918-A1 PROTEASOME INHIBITORS AND METHODS OF USING THE SAME CEPHALON, INC. (US) 2009-11-26 US claimed
EP-1660507-B1 PROTEASOME INHIBITORS AND METHODS OF USING THE SAME CEPHALON INC (US) 2009-08-05 EP claimed
WO-2009005269-A2 PHARMACEUTICAL COMPOSITION FOR PREVENTINTION AND TREATMENT OF RESTENOSIS COMPRISING ISOXAZOLE DERIVATIVES SK HOLDINGS CO., LTD. (KR) 2009-01-08 WO claimed
EP-1971600-A1 ISOXAZOLE DERIVATIVES AND USE THEREOF SK Holdings Co., Ltd. (KR) 2008-09-24 EP claimed
CN-101103026-A Bicyclic heteroaryl derivatives for treating viruses GENELABS INC (US) 2008-01-09 CN claimed
EP-0592490-A4 AMINO ACID DERIVATIVE ANTICONVULSANT RES CORP TECHNOLOGIES INC (US) 1994-08-17 EP claimed
EP-0592490-A1 AMINO ACID DERIVATIVE ANTICONVULSANT RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1994-04-20 EP claimed
EP-0548338-A1 PROCESS FOR THE PREPARATION OF CEPHALOSPORINS INTERMEDIATES. ANTIBIOTICOS SPA (IT) 1993-06-30 EP claimed
WO-1993002085-A1 PROCESS FOR THE PREPARATION OF CEPHALOSPORINS INTERMEDIATES ANTIBIOTICOS S.P.A. (IT) 1993-02-04 WO claimed
US-4978613-A Beta-lactamase assay employing chromogenic precipitating substrates ABBOTT LABORATORIES (US) 1990-12-18 US claimed
US-4958018-A REACTING A 3-HALOMETHYL-3-CEPHEM WITH A LEAD REDUCING AGENT OTSUKA KAGAKU KABUSHIKI KAISHA (JP) 1990-09-18 US claimed
US-4342869-A Cephalosporin antibiotics MERCK & CO., INC. (US) 1982-08-03 US claimed
US-4338437-A Cephalosporin antibiotics MERCK & CO., INC. (US) 1982-07-06 US claimed
US-4338438-A Cephalosporin antibiotics MERCK & CO., INC. (US) 1982-07-06 US claimed
US-4297488-A 7-α-Methoxy cephalosporins MERCK & CO., INC. (US) 1981-10-27 US claimed